Fred Alger Management, LLC Sage Therapeutics, Inc. Transaction History

Fred Alger Management, LLC

$19.7 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$40.26 - $57.37 $4.22 Million - $6.02 Million	-104,851 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $4.56 Million - $6.58 Million	83,037 Added 380.66%	104,851 $5.96 Million
Q1 2021 May 17, 2021	SELL	$70.65 - $96.76 $1.41 Million - $1.94 Million	-20,016 Reduced 47.85%	21,814 $1.63 Million
Q4 2020 Feb 16, 2021	SELL	$58.41 - $89.06 $6.18 Million - $9.42 Million	-105,738 Reduced 71.65%	41,830 $3.62 Million
Q3 2020 Nov 13, 2020	BUY	$41.13 - $62.45 $6.07 Million - $9.22 Million	147,568 New	147,568 $9.02 Million

Q2 2020 Aug 14, 2020	SELL	$25.95 - $43.15 $311,400 - $517,800	-12,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $78,450 - $231,719	-3,000 Reduced 20.0%	12,000 $345,000
Q4 2019 Feb 14, 2020	BUY	$60.18 - $154.77 $451,350 - $1.16 Million	7,500 Added 100.0%	15,000 $1.08 Million
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $70,145 - $94,980	500 Added 7.14%	7,500 $1.05 Million
Q2 2019 Aug 14, 2019	BUY	$157.85 - $183.09 $157,850 - $183,090	1,000 Added 16.67%	7,000 $1.28 Million
Q1 2019 May 14, 2019	BUY	$89.33 - $163.65 $535,980 - $981,900	6,000 New	6,000 $954,000
Q4 2018 Feb 14, 2019	SELL	$81.94 - $139.71 $1.64 Million - $2.79 Million	-19,989 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$138.11 - $169.04 $479,379 - $586,737	-3,471 Reduced 14.8%	19,989 $2.82 Million
Q2 2018 Jul 19, 2018	BUY	$140.36 - $175.76 $600,179 - $751,549	4,276 Added 22.29%	23,460 $3.67 Million
Q1 2018 May 10, 2018	BUY	$152.15 - $192.33 $1.93 Million - $2.44 Million	12,684 Added 195.14%	19,184 $3.09 Million
Q4 2017 Feb 14, 2018	SELL	$60.72 - $167.34 $213,066 - $587,196	-3,509 Reduced 35.06%	6,500 $1.07 Million
Q3 2017 Nov 14, 2017	BUY	$61.4 - $88.52 $614,552 - $885,996	10,009	10,009 $624,000

Others Institutions Holding SAGE

# of Institutions

222

Shares Held

52.7M

Call Options Held

207K

Put Options Held

191K

Vanguard Group Inc Valley Forge, PA

5.75M
Shares

$62 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.48M
Shares

$59.1 Million
1.65% of portfolio
Black Rock Inc. New York, NY

4.89M
Shares

$52.7 Million
0.0% of portfolio
Wellington Management Group LLP Boston, MA

4.75M
Shares

$51.2 Million
0.02% of portfolio
State Street Corp Boston, MA

4.49M
Shares

$48.5 Million
0.0% of portfolio

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $641M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Account